Opinion on medicine for use outside EU: Arpraziquantel , arpraziquantel, 14/12/2023 Positive opinion
Opinion on medicine for use outside EU: Arpraziquantel , arpraziquantel, 14/12/2023 Positive opinion
Opinion on medicine for use outside EU: Arpraziquantel , arpraziquantel, 14/12/2023 Positive opinion
Veterinary medicines European public assessment report (EPAR): Mometamax Ultra, gentamicin,posaconazole,mometasone furoate, Status: Authorised
Decision of the Executive Director on fee incentives for scientific advice, marketing authorisation applications and pre-authorisation inspections in the ATMP support pilot for academia
Questions and answers on EMA pilot offering enhanced support to academic and non- profit developers of Advanced Therapy Medicinal Products (ATMPs)
Veterinary medicines European public assessment report (EPAR): Evanovo, Eimeria acervulina, strain 044, live / Eimeria maxima, strain 013, live / Eimeria praecox, strain 007, live / Eimeria tenella, strain 004, live, Status: Authorised
Epirubicin: List of nationally authorised medicinal products - PSUSA/00001234/202306
Veterinary medicines European public assessment report (EPAR): DogStem, equine umbilical cord-derived mesenchymal stem cells, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Coxatab, firocoxib, Status: Authorised
Progress update on pilot for academic and non-profit developers of advanced therapy medicines
Veterinary medicines European public assessment report (EPAR): Cortaderm, hydrocortisone aceponate, Status: Authorised